Table 2.

Patients’ laboratory tests and the type of cancer.

	Patient with Cancer type		WBC	Hb	PLT	RDW	LDH	Lymph count
1	Breast Cancer		2900	12.3	89000	13.2	403	41.6
2	Lung Cancer		15200	8.9	215000	15.3	612	6.4
3	Esophageal Cancer		3200	10.1	404000	13.4	259	9.9
4	Oral SCC		4200	12.3	252000	14.1	570	18.2
5	Hypopharyngeal Cancer		19400	7.3	276000	17.5		3.5
6	Gastric Cancer		10300	11.6	204000	16.2	587	17.1
7	CLL		116000	11.5	44000	15.2	786	0
8	Metastatic Lung Cancer		5300	10.5	256000	17.4	539	37.6
9	Prostate cancer		4300	13.4	126000	13.6	405	18.7
10	Glioblastoma multiforme
11	Prostate Cancer		5000	16.6	171000	13.5	514	23.9
12	Breast Cancer		7500	12	191000	12.4	419	10.7
13	Thyroid Cancer		4800	13.8	160000	13.1	316	16.8
14	Gastric Cancer		7.9	9.7	317	14.9	316	25.3
15	CLL		79.6	8.8	31	15.3	887	87.8
16	Ovarian Cancer		15.6	12.2	473	15.8	298	22.3
17	Non Hodgkin Lymphoma + Prostate		2.5	8.3	30	21.6	548	11.8
18	Multiple Myeloma		0.6	7	65	15.1	194
19	RCC		4	10.4	114	15.1	659	21.3
20	Laryngeal Carcinoma						254
21	Chollangiocarcinoma		0.8	11.2	167	15.1	1338
22	Hodgkin Lymphoma		6.5	12.5	90	13.5	197	10.1
23	Anal Cancer		3.2	13.6	70	14.2	408	13.4
24	Astrocytoma		3.7	13.2	149	15.3	753	35.6
25	Lung Cancer		9	10.3	211	17.8	351	14.7
26	Breast Cancer		7.9	12.1	279	13.3	416	21.8
27	Esophageal Cancer		0.3	10.1	33	16.8	445
28	Gastric Cancer		2.6	10.3	172	13.2	461	37.2
Graft patient	Sex	Age	Underlying disease HTN	SPO2	WBC	Hb 16.2	PLT	RDW	LDH
Patient 1	Male	41		93	6100		133000	12.1	319
Patient 2	Female	27	HTN	89	6500	8.4	234000	12.8	769
Patient 3	Male	50	DM HTN	82	7000	13.2	177	13.5	1145
Patient 4	Female	61	HTN	93	4800	9.8	130	12.4	477
Patient 5	Male	64		97	11300	11.8	166	14.4	209

SCC: Squamous Cell Carcinoma; CLL: Chronic Lymphocytic Leukemia; GBM: Glioblastoma Multiform; RCC: Renal Cell Carcinoma; WBC: White Blood Cell; Hb: Hemoglobin; PLT: Platelets; RDW: Red Distribution Width; LDH: Lactate Dehydrogenase; SPO2: Oxygen Saturation; HTN: Hypertension; DM: Diabetes Mellitus